Alcon Inc. (ALC) stock — is it a good business?

Alcon Inc. (ALC) stock — is it a good business? — InspectStocks

How it makes money

Surgical products and services56%
Vision-care products45%

Shares of revenue are estimates for FY2025, not figures from a filing.

Competes with

What it sells6

UNITY VCS and UNITY CS
Equipment systems used for retinal and cataract surgery. They help surgeons remove eye tissue or a cloudy natural lens and replace it.
PanOptix Pro
An artificial lens implanted during cataract surgery, designed to help patients see at near, middle and far distances.
Hydrus Microstent
A small device implanted during cataract surgery to help fluid drain from the eye and lower pressure in some people with glaucoma.

Show 3 more

DAILIES TOTAL1
A daily disposable contact lens designed with a high-water-content surface for comfort.
Systane
Eye drops that temporarily relieve burning and irritation associated with dry eye.
TRYPTYR
Prescription eye drops for dry eye disease that stimulate natural tear production.

Who buys it5

Hospitals and ambulatory surgery centers buy surgical equipment, implanted lenses and procedure supplies.
Eye surgeons select and use Alcon’s surgical products and equipment in procedures.
Optometrists and ophthalmologists recommend or sell contact lenses and eye-health products to patients.

Show 2 more

Optical chains, retailers and pharmacies sell contact lenses and eye-health products to consumers.
Distributors sell and deliver products in markets where Alcon does not have local operations.

What it stands on, and what could break it

What the business leans on

1Sales of contact lenses and eye-health products are influenced by recommendations from eye-care professionals, consumer preferences and retailer access.
2Some components used in surgical, dry-eye and pharmaceutical products are available from only one or a limited number of health-authority-approved suppliers.
3Sales of prescription products and products used in surgery depend in part on regulatory approval and health-insurance or government reimbursement rules.

What could go wrong

1Regulatory approvals, manufacturing requirements and ongoing product-safety rules can delay launches or lead to production interruptions, recalls or restrictions on sales.
2Disruption at important facilities or shortages of components from single or limited suppliers could interrupt production and delay customer deliveries.
3Competition, reimbursement changes and price controls could make it harder to sell products at current prices; Alcon also depends on developing and launching products that meet medical and customer needs.

Full financial statements →

About Alcon Inc.

Alcon makes equipment and disposable supplies used in cataract, retinal, laser-vision and glaucoma surgery, as well as artificial lenses implanted during cataract operations. It also sells daily and reusable contact lenses and eye drops for dry eye, allergies, glaucoma and contact-lens care. Hospitals and surgery centers buy surgical products, while eye-care practices, retailers, pharmacies and distributors sell or prescribe its vision-care products.

Head office: Geneva, Switzerland
Founded: 1945
Employees: 25,000+ (Q2 2026, high)
Listed on: NYSE
Financial year ends: December 31

Built from Alcon Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.

Keep exploring

The themes Alcon is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Highest-graded in Medical Instruments and Supplies

Graded A or B and worth $2B or more: A first, then the largest.

All 49 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises